Supplemental Figure 3 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 3: IgG immunological response: IgG responses to AR LBD protein (panel A), PSA protein (panel B), and tetanus toxoid (panel C) were evaluated by Luminex. Sera samples were assessed at a 1:100 dilution from the time points indicated. Data were plotted over time, subtracting the pre-treatment value to evaluate change in post-treatment specimens.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362409276